Tag Archives: Erinna Bowman

Cellular immune function in ME/CFS: increased MAIT cell frequency

Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), by Jacqueline M Cliff, Elizabeth C King, Ji-Sook Lee, Nuno Sepulveda, Asia-Sofia Wolf, Caroline Kingdon, Erinna Bowman, Hazel M. Dockrell, Luis C. Nacul, Eliana Lacerda, Eleanor Riley in Front. Immunol., 16 April … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Cellular immune function in ME/CFS: increased MAIT cell frequency

Functional status & well-being in people with ME/CFS compared with people with MS & healthy controls

Research abstract: Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls, by Caroline C. Kingdon, Erinna W. Bowman, Hayley Curran, Luis Nacul, Eliana M. Lacerda in PharmacoEconomics Open 2018 pp 1-12  [Online: 13 March 2018] Background: People with myalgic encephalomyelitis/chronic fatigue … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on Functional status & well-being in people with ME/CFS compared with people with MS & healthy controls

Selection bias & disease misclassification undermine the validity of ME/CFS studies

Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome has been a controversial diagnosis, resulting in tensions between patients and professionals providing them with care. A major constraint limiting progress has been the lack of a ‘gold standard’ for diagnosis; with a number … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Selection bias & disease misclassification undermine the validity of ME/CFS studies